Elevated levels of low density lipoprotein (LDL) are an independent risk factor for cardiovascular disease. LDL however is not a single entity but consists of a heterogeneous group of particles with smaller dense particles being the most atherogenic. To test the hypothesis that malignant hypertension (MHT), the most severe form of hypertension, is associated with an abnormal lipid profile, and that this may contribute to the complications of MHT, we studied 18 patients presenting with this condition (49.4 (11.4) years; 16 male; 236/141). LDL subfraction profile was measured by disc polyacrylamide gel electrophoresis using a validated scoring system to calculate the mean (locus) and standard deviation (spread) mobility of LDL. Results were compared with 41 patients with non-malignant, untreated hypertension (mean age 53.9 years; 24 male systolic/diastolic blood pressure 173/100) and 45 normotensive patients with normal coronary angiograms (58 (10.6) years; 22 male; 136/80).
To investigate the determinants of endothelial cell damage in elderly hypertensives, we measured the plasma von Willebrand factor levels by a recently developed enzyme-linked immunosorbent assay using monoclonal antibody for the functional epitope. Plasma von Willebrand factor level was markedly higher in elderly normotensives (nϭ42) than in younger normotensives (nϭ39) (127% vs 88%, pϽ0.0001), and was further increased in elderly hypertensives (nϭ68) (148%, pϽ.05 vs elderly normotensives). The von Willebrand factor level was positively correlated with body mass index in younger normotensives (rϭ0.41, pϽ0.01), with systolic blood pressure in elderly normotensives (rϭ0.41, pϽ0.01), and with age (rϭ0.44, pϽ0.001) and fibrinogen level (rϭ0.37, pϽ0.01) in elderly hypertensives. In elderly hypertensive subjects (nϭ150), von Willebrand factor level had a stronger positive correlation with 24 hour systolic blood pressure (rϭ0.41, pϽ0.0001) measured by ambulatory blood pressure monitoring than with clinic systolic blood pressure (rϭ0.33, pϽ0.0001). In conclusion, in hypertensive elderly, endothelial cell damage was related to along with systolic BP and fibrinogen levels, indicating a prethrombotic condition.
Key Words: von Willebrand factor; elderly; hypertension; ambulatory blood pressure; endothelial cell damage Kazuomi Kario, Takefumi Matsuo, Hiroko Kobayashi, Kazuyuki Shimada. Thomas G Pickering Hypertension Center, The New York Hospital/Cornell University Medical College, New York To investigate the association of silent cerebral infarction (a predisposing condition to stroke) with insulin resistance syndrome, fibrinolytic impairment and endothelial damage in older hypertensives, we performed 75g oral glucose tolerance test (OGTT) and brain magnetic resonance imaging and measured insulin and fibrinolytic and endothelial parameters in 123 asymptomatic hypertensives (mean age: 69 years) divided into a non-infarction group without any lacunae (nϭ43), a "few infarction" group with 1 or 2 (nϭ32), and a multiple infarction group with 3 or more (nϭ48). The multiple infarction group was older and had higher levels of 24-hr systolic blood pressure (SBP), 2-hr insulin area under curve (AUC) (an indicator of insulin resistance), thrombin generation markers [prothrombin fragment 1ϩ2 (F1ϩ2)], plasminogen activator inhibitor-1 (PAI-1), D-dimer, and an endothelial damage marker [von Willebrand factor (vWF)] than other 2 groups, while the plasmin generation marker [plasmin-␣ 2 -lasmin complex (PIC)] level was not increased in this group. There were no differences in these factors except D-dimer between the non-infarction and the few infarction groups. The insulin AUC was positively correlated with PAI-1 and vWF levels (PϽ0.01), and the PAI-1 level was negatively correlated with the PIC level (PϽ0.02). Multiple logistic analysis showed that 24-hr SBP, vWF, PAI-1, and F1ϩ2 were independently associated with multiple infarction. In conclusion, the imbalance between hypercoagulability and impaired fibrinolysis related to hyperin-
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Median (range)
Controls MHT
Essential Hypertension
Total cholesterol (mmol/L) 5.23 (4.96-5.5) 6.12 (5.31-6.93)* 5.72 (5.41-6.03)** Triglycerides (mmol/L) 
